Federated Hermes, Inc. Orchard Therapeutics PLC Transaction History

Federated Hermes, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.45 - $0.69 $41,322 - $63,361	91,828 Added 1.11%	8,401,687 $4.2 Million
Q4 2021 Feb 14, 2022	BUY	$1.16 - $2.23 $2.75 Million - $5.29 Million	2,372,945 Added 39.97%	8,309,859 $11 Million
Q3 2021 Nov 15, 2021	BUY	$2.24 - $4.29 $7.32 Million - $14 Million	3,269,114 Added 122.54%	5,936,914 $13.7 Million
Q4 2020 Feb 12, 2021	BUY	$3.86 - $5.07 $647,708 - $850,746	167,800 Added 6.71%	2,667,800 $11.5 Million
Q3 2020 Nov 12, 2020	SELL	$4.11 - $6.45 $745,973 - $1.17 Million	-181,502 Reduced 6.77%	2,500,000 $10.3 Million
Q2 2020 Aug 13, 2020	BUY	$5.75 - $11.99 $2.48 Million - $5.17 Million	431,502 Added 19.18%	2,681,502 $16.1 Million
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $12.2 Million - $18.7 Million	1,200,000 Added 114.29%	2,250,000 $30.9 Million
Q3 2019 Nov 14, 2019	BUY	$11.88 - $16.72 $12.5 Million - $17.6 Million	1,050,000 New	1,050,000 $12.5 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.